Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular session 21% higher on news the company plans to conduct a clinical study of its gastric balloon ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more than 40 years, but says when so called GLP-1 drugs made from semaglutide ...

Paris Fashion Week was visited by Whoopi Goldberg recently, with the View host and EGOT winner attending a fashion ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...